Sentinel Lymph Node Biopsy

Published on 16/04/2015 by admin

Filed under Surgery

Last modified 16/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2038 times

Chapter 48

Sentinel Lymph Node Biopsy

Introduction

Several cancers, including breast cancer and melanoma, are similar in that regional lymph node metastasis greatly impacts treatment, chance of recurrence, and survival rate. Therefore, management of regional lymph node metastasis is of great interest in patients with these diseases. Previously, the standard of care for a patient diagnosed with invasive cancer was to perform a lymphadenectomy—removal of all regional lymph tissue. Although associated with high morbidity, the procedure was performed to diagnose and treat regional lymph node disease and to correctly stage a patient for further systemic therapy.

Sentinel lymph node biopsy (SLNB) has dramatically changed the management of breast cancer and melanoma patients. The procedure was first described in 1977 by Cabanas for penile cancer; diagnostic and therapeutic applications have since grown. Instead of routine lymphadenectomy, patients who are clinically node negative can now be accurately staged with minimal morbidity.

Dye/Radiotracer and Injection Sites

The injection site for the blue dye or the radiotracer can be either over the tumor or the areola (Fig. 48-1). In the operating room the surgeon then looks for a blue lymph node (if dye is used), a radioactive lymph node (if radiotracer is used), or both. With a radiotracer, multiple nodes may be radioactive. It is important to search for the node with the highest level of radioactivity. This node, as well as all nodes with more than 10% of the highest count, should be removed for pathologic evaluation.

In breast cancer, the choice of blue dye or radiolabeled colloid to perform SLNB has been the subject of multiple studies. Some studies report that the combination of blue dye and radiolabeled colloid is optimal for identification of sentinel nodes, whereas other studies show equivalence. In general, the choice of blue dye or radiolabeled colloid should be dictated by surgeon preference as well as contraindications in patients (e.g., pregnancy, allergy).

Lymphatic Drainage

Buy Membership for Surgery Category to continue reading. Learn more here